Catret M, Anselmi E, Ivorra M D, Elorriaga M, Tur R, D'Ocón M P
Departamento de Farmacología, Facultad de Farmacia, Universitat de València, Burjassot, Spain.
J Pharm Pharmacol. 1998 Nov;50(11):1267-73. doi: 10.1111/j.2042-7158.1998.tb03344.x.
The action of 1S,1'S-tetrandrine, a bisbenzyltetrahydroisoquinoline alkaloid, on alpha1-adrenoceptors has been compared with that of its isomer 1R,1'S-isotetrandrine. The work includes binding assays to analyse the affinity of these products for the [3H]prazosin binding site of rat cerebral cortical membranes and functional studies on rat isolated aorta to examine the effects of both alkaloids on intracellular calcium processes related or not to alpha-adrenoceptor activation. A radioligand receptor-binding study showed that both compounds interacted with the alpha1-adrenoceptors displacing [3H]prazosin from the specific binding site. The Ki values (inhibition constants) were 0.69+/-0.12 and 1.6+/-0.4 microM for tetrandrine and isotetrandrine, respectively. The functional studies showed that both alkaloids concentration-dependently inhibited noradrenaline-induced contraction in Ca2+-free solution (IC50 values, i.e. the concentrations needed to induce 50% inhibition, were 252.8 and 174.9 microM for tetrandrine and isotetrandrine, respectively), the spontaneous contractile response elicited by extracellular calcium after depletion of noradrenaline-sensitive intracellular stores (increase in resting tone; IC50 values 11.6 and 19.6 microM for tetrandrine and isotetrandrine, respectively) and the refilling of intracellular Ca2+ stores sensitive to noradrenaline (IC50 values 7.4 and 14.9 microM for tetrandrine and isotetrandrine, respectively). The results show that tetrandrine and isotetrandrine interact with alpha1-adrenoceptors by displacing the [3H]prazosin binding site and that both compounds inhibit mainly the Ca2+-dependent process and have less action on alpha1-adrenoceptors. Tetrandrine is more potent than isotetrandrine.
双苄基四氢异喹啉生物碱1S,1'S-粉防己碱对α1-肾上腺素能受体的作用已与其异构体1R,1'S-异粉防己碱进行了比较。这项工作包括结合试验,以分析这些产物对大鼠大脑皮层膜[3H]哌唑嗪结合位点的亲和力,以及对大鼠离体主动脉的功能研究,以检查这两种生物碱对与α-肾上腺素能受体激活相关或不相关的细胞内钙过程的影响。一项放射性配体受体结合研究表明,这两种化合物都与α1-肾上腺素能受体相互作用,从特异性结合位点取代[3H]哌唑嗪。粉防己碱和异粉防己碱的Ki值(抑制常数)分别为0.69±0.12和1.6±0.4微摩尔/升。功能研究表明,这两种生物碱在无钙溶液中均浓度依赖性地抑制去甲肾上腺素诱导的收缩(IC50值,即诱导50%抑制所需的浓度,粉防己碱和异粉防己碱分别为252.8和174.9微摩尔/升)、去甲肾上腺素敏感的细胞内储存耗尽后细胞外钙引发的自发收缩反应(静息张力增加;粉防己碱和异粉防己碱的IC50值分别为11.6和19.6微摩尔/升)以及对去甲肾上腺素敏感的细胞内钙储存的再填充(粉防己碱和异粉防己碱的IC50值分别为7.4和14.9微摩尔/升)。结果表明,粉防己碱和异粉防己碱通过取代[3H]哌唑嗪结合位点与α1-肾上腺素能受体相互作用,且这两种化合物主要抑制钙依赖性过程,对α1-肾上腺素能受体的作用较小。粉防己碱比异粉防己碱更有效。